Association of the HLA-B*52 allele with non-progression to AIDS in Brazilian HIV-1-infected individuals

Genes and Immunity

Volumn 15, Issue 4, 2014, Pages 256-262

  Teixeira, S L M ^a   De Sa N B R ^a   Campos, D P ^b   Coelho, A B ^b   Guimaraes M L ^a   Leite, T C N F ^a   Veloso, V G ^b   Morgado, M G ^a  

^a INSTITUTO OSWALDO CRUZ   (Brazil)

^b Funda??o Oswaldo Cruz   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

HLA B52 ANTIGEN;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ALLELE; ARTICLE; CONTROLLED STUDY; DISEASE COURSE; FEMALE; GENE FREQUENCY; HAZARD RATIO; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; LONG TERM NONPROGRESSOR; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RAPID PROGRESSOR; TYPICAL PROGRESSOR; ADOLESCENT; BRAZIL; CLINICAL TRIAL; GENETICS; IMMUNOLOGY; MIDDLE AGED;

HUMAN IMMUNODEFICIENCY VIRUS 1;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ADOLESCENT; ADULT; ALLELES; BRAZIL; FEMALE; GENE FREQUENCY; HIV-1; HLA-B52 ANTIGEN; HUMANS; MALE; MIDDLE AGED;

EID: 84902074708     PISSN: 14664879     EISSN: 14765470     Source Type: Journal    
DOI: 10.1038/gene.2014.14     Document Type: Article

References (60)

1. Sharma G, Kaur G, Mehra N. Genetic correlates influencing immunopathogenesis of HIV infection. Indian J Med Res 2011; 134: 749-768
2. Alexander L, Weiskopf E, Greenough TC, Gaddis NC, Auerbach MR, Malim MH et al. Unusual polymorphisms in human immunodeficiency virus type 1 associated with nonprogressive infection. J Virol 2000; 74: 4361-4376. (Pubitemid 30214444
3. Mariani R, Kirchhoff F, Greenough TC, Sullivan JL, Desrosiers RC, Skowronski J. High frequency of defective nef alleles in a long-Term survivor with nonprogressive human immunodeficiency virus type 1 infection. J Virol 1996; 70: 7752-7764. (Pubitemid 26339081
4. Michael NL, Chang G, d'Arcy LA, Ehrenberg PK, Mariani R, Busch MP et al. Defective accessory genes in a human immunodeficiency virus type 1-infected long-Term survivor lacking recoverable virus. J Virol 1995; 69: 4228-4236
5. Brumme ZL, Li C, Miura T, Sela J, Rosato PC, Brumme CJ et al. Reduced replication capacity of NL4-3 recombinant viruses encoding reverse transcriptase-integrase sequences from HIV-1 elite controllers. J Acquir Immune Defic Syndr 2011; 56: 100-108
6. Deacon NJ, Tsykin A, Solomon A, Smith K, Ludford-Menting M, Hooker DJ et al. Genomic structure of an attenuated quasi species of HIV-1 from a blood transfusion Donor and recipients. Science 1995; 270: 988-991
7. Betts MR, Nason MC, West SM, De Rosa SC, Migueles SA, Abraham J et al. HIV nonprogressors preferentially maintain highly functional HIV-specific CD8θ T cells. Blood 2006; 107: 4781-4789. (Pubitemid 43882629
8. Ferre AL, Hunt PW, Critchfield JW, Young DH, Morris MM, Garcia JC et al. Mucosal immune responses to HIV-1 in elite controllers: A potential correlate of immune control. Blood 2009; 113: 3978-3989
9. Migueles SA, Laborico AC, Shupert WL, Sabbaghian MS, Rabin R, Hallahan CW et al. HIV-specific CD8θ T cell proliferation is coupled to perforin expression and is maintained in nonprogressors. Nat Immunol 2002; 3: 1061-1068
10. Migueles SA, Osborne CM, Royce C, Compton AA, Joshi RP, Weeks KA et al. Lytic granule loading of CD8θ T cells is required for HIV-infected cell elimination associated with immune control. Immunity 2008; 29: 1009-1021
11. Ndhlovu ZM, Proudfoot J, Cesa K, Alvino DM, McMullen A, Vine S et al. Elite controllers with low to absent effector CD8θ T cell responses maintain highly functional, broadly directed central memory responses. J Virol 2012; 86: 6959-6969
12. Saez-Cirion A, Lacabaratz C, Lambotte O, Versmisse P, Urrutia A, Boufassa F et al. HIV controllers exhibit potent CD8 T cell capacity to suppress HIV infection ex vivo and peculiar cytotoxic T lymphocyte activation phenotype. Proc Natl Acad Sci USA 2007; 104: 6776-6781. (Pubitemid 47175577
13. Saez-Cirion A, Sinet M, Shin SY, Urrutia A, Versmisse P, Lacabaratz C et al. Heterogeneity in HIV suppression by CD8 T cells from HIV controllers: Association with Gag-specific CD8 T cell responses. J Immunol 2009; 182: 7828-7837
14. Chevalier MF, Julg B, Pyo A, Flanders M, Ranasinghe S, Soghoian DZ et al. HIV-1-specific interleukin-21θ CD4θ T cell responses contribute to durable viral control through the modulation of HIV-specific CD8θ T cell function. J Virol 2011; 85: 733-741
15. Lambotte O, Ferrari G, Moog C, Yates NL, Liao HX, Parks RJ et al. Heterogeneous neutralizing antibody and antibody-dependent cell cytotoxicity responses in HIV-1 elite controllers. AIDS 2009; 23: 897-906
16. Barblu L, Machmach K, Gras C, Delfraissy JF, Boufassa F, Leal M et al. Plasmacytoid dendritic cells (pDCs) from HIV controllers produce interferon-Alpha and differentiate into functional killer pDCs under HIV activation. J Infect Dis 2012; 206: 790-801
17. Machmach K, Leal M, Gras C, Viciana P, Genebat M, Franco E et al. Plasmacytoid dendritic cells reduce HIV production in elite controllers. J Virol 2012; 86: 4245-4252
18. Saez-Cirion A, Hamimi C, Bergamaschi A, David A, Versmisse P, Melard A et al. Restriction of HIV-1 replication in macrophages and CD4θ T cells from HIV controllers. Blood 2011; 118: 955-964
19. Vieillard V, Fausther-Bovendo H, Samri A, Debre P. Specific phenotypic and functional features of natural killer cells from HIV-infected long-Term nonprogressors and HIV controllers. J Acquir Immune Defic Syndr 2010; 53: 564-573
20. Pereyra F, Jia X, McLaren PJ, Telenti A, de Bakker PI, Walker BD et al. The major genetic determinants of HIV-1 control affect HLA class I peptide presentation. Science 2010; 330: 1551-1557
21. Fellay J, Shianna KV, Ge D, Colombo S, Ledergerber B, Weale M et al. A wholegenome association study of major determinants for host control of HIV-1. Science 2007; 317: 944-947. (Pubitemid 47301321
22. Bailey JR, Williams TM, Siliciano RF, Blankson JN. Maintenance of viral suppression in HIV-1-infected HLA-B.57θ elite suppressors despite CTL escape mutations. J Exp Med 2006; 203: 1357-1369. (Pubitemid 43736603
23. Lambotte O, Boufassa F, Madec Y, Nguyen A, Goujard C, Meyer L et al. HIV controllers: A homogeneous group of HIV-1-infected patients with spontaneous control of viral replication. Clin Infect Dis 2005; 41: 1053-1056. (Pubitemid 41368233
24. Migueles SA, Sabbaghian MS, Shupert WL, Bettinotti MP, Marincola FM, Martino L et al. HLA B.5701 is highly associated with restriction of virus replication in a subgroup of HIV-infected long term nonprogressors. Proc Natl Acad Sci USA 2000; 97: 2709-2714. (Pubitemid 30159236
25. Dean M, Carrington M, Winkler C, Huttley GA, Smith MW, Allikmets R et al. Genetic restriction of HIV-1 infection and progression to AIDS by a deletion allele of the CKR5 structural gene. Hemophilia Growth and Development Study, Multicenter AIDS Cohort Study, Multicenter Hemophilia Cohort Study, San Francisco City Cohort, ALIVE Study. Science 1996; 273: 1856-1862. (Pubitemid 26322495
26. Limou S, Le Clerc S, Coulonges C, Carpentier W, Dina C, Delaneau O et al. Genomewide association study of an AIDS-nonprogression cohort emphasizes the role played by HLA genes (ANRS Genomewide Association Study 02). J Infect Dis 2009; 199: 419-426
27. Carrington M, Walker BD. Immunogenetics of spontaneous control of HIV. Annu Rev Med 2012; 63: 131-145
28. Trachtenberg E, Korber B, Sollars C, Kepler TB, Hraber PT, Hayes E et al. Advantage of rare HLA supertype in HIV disease progression. Nat Med 2003; 9: 928-935. (Pubitemid 36889937
29. O'Brien SJ, Nelson GW. Human genes that limit AIDS. Nat Genet 2004; 36: 565-574. (Pubitemid 38715980
30. Altfeld M, Kalife ET, Qi Y, Streeck H, Lichterfeld M, Johnston MN et al. HLA Alleles Associated with Delayed Progression to AIDS Contribute Strongly to the Initial CD8(θ) T Cell Response against HIV-1. PLoS Med 2006; 3: E403
31. Huang X, Ling H, Mao W, Ding X, Zhou Q, Han M et al. Association of HLA-A, B, DRB1 alleles and haplotypes with HIV-1 infection in Chongqing, China. BMC Infect Dis 2009; 9: 201
32. Kiepiela P, Leslie AJ, Honeyborne I, Ramduth D, Thobakgale C, Chetty S et al. Dominant influence of HLA-B in mediating the potential co-evolution of HIV and HLA. Nature 2004; 432: 769-775
33. Gao X, O'Brien TR, Welzel TM, Marti D, Qi Y, Goedert JJ et al. HLA-B alleles associate consistently with HIV heterosexual transmission, viral load, and progression to AIDS, but not susceptibility to infection. AIDS 2010; 24: 1835-1840
34. Kaslow RA, Carrington M, Apple R, Park L, Munioz A, Saah AJ et al. Influence of combinations of human major histocompatibility complex genes on the course of HIV-1 infection. Nat Med 1996; 2: 405-411
35. Hendel H, Caillat-Zucman S, Lebuanec H, Carrington M, O'Brien S, Andrieu JM et al. New class I and II HLA alleles strongly associated with opposite patterns of progression to AIDS. J Immunol 1999; 162: 6942-6946. (Pubitemid 29309424
36. Altfeld M, Addo MM, Rosenberg ES, Hecht FM, Lee PK, Vogel M et al. Influence of HLA-B57 on clinical presentation and viral control during acute HIV-1 infection. AIDS 2003; 17: 2581-2591. (Pubitemid 38402336
37. Catano G, Kulkarni H, He W, Marconi VC, Agan BK, Landrum M et al. HIV-1 diseaseinfluencing effects associated with ZNRD1, HCP5 and HLA-C alleles are attributable mainly to either HLA-A10 or HLA-B57 alleles. PLoS ONE 2008; 3: E3636
38. Antoni G, Guergnon J, Meaudre C, Samri A, Boufassa F, Goujard C et al. MHCdriven HIV-1 control on the long run is not systematically determined at early times post-HIV-1 infection. AIDS 2013; 27: 1707-1716
39. Klein MR, Keet IP, D'Amaro J, Bende RJ, Hekman A, Mesman B et al. Associations between HLA frequencies and pathogenic features of human immunodeficiency virus type 1 infection in seroconverters from the Amsterdam cohort of homosexual men. J Infect Dis 1994; 169: 1244-1249. (Pubitemid 24164586
40. Gao X, Nelson GW, Karacki P, Martin MP, Phair J, Kaslow R et al. Effect of a single amino acid change in MHC class I molecules on the rate of progression to AIDS. N Engl J Med 2001; 344: 1668-1675. (Pubitemid 32479964
41. Liu R, Paxton WA, Choe S, Ceradini D, Martin SR, Horuk R et al. Homozygous defect in HIV-1 coreceptor accounts for resistance of some multiply-exposed individuals to HIV-1 infection. Cell 1996; 86: 367-377. (Pubitemid 26272077
42. Samson M, Libert F, Doranz BJ, Rucker J, Liesnard C, Farber CM et al. Resistance to HIV-1 infection in caucasian individuals bearing mutant alleles of the CCR-5 chemokine receptor gene. Nature 1996; 382: 722-725
43. Matthews PC, Listgarten J, Carlson JM, Payne R, Huang KH, Frater J et al. Co-operative additive effects between HLA alleles in control of HIV-1. PLoS ONE 2012; 7: E47799
44. Teixeira SL, Bastos FI, Hacker MA, Morgado MG. Distribution of CCR5 genotypes and HLA Class I B alleles in HIV-1 infected and uninfected injecting drug users from Rio de Janeiro, Brazil. Infect Genet Evol 2009; 9: 638-642
45. Casado C, Colombo S, Rauch A, Marti'nez R, Günthard HF, Garcia S et al. Host and viral genetic correlates of clinical definitions of HIV-1 disease progression. PLoS ONE 2010; 5: E11079
46. Girardi E, Aloisi MS, Arici C, Pezzotti P, Serraino D, Balzano R et al. Delayed presentation and late testing for HIV: Demographic and behavioral risk factors in a multicenter study in Italy. J Acquir Immune Defic Syndr 2004; 36: 951-959. (Pubitemid 38944091
47. Grangeiro A, Escuder MM, Menezes PR, Alencar R, Ayres de Castilho E. Late entry into HIV care: Estimated impact on AIDS mortality rates in Brazil, 2003-2006. PLoS ONE 2011; 6: E14585
48. Kerr LRFS, Mota RS, Kendall C, Dourado I. HIV infection and late diagnosis among MSM in Brazil. In: XIX International AIDS Conference 2012 Washington DC, USA, 2012 (abstract MOPE280
49. Ramos Jr NA, Matida LH, Alencar CH, Hearst N, Heukelbach J. Late-stage diagnosis of HIV infection in Brazilian children: Evidence from two national cohort studies. Cadernos de Sau'de Pu'blica 2013; 29: 10
50. Kaur G, Mehra N. Genetic determinants of HIV-1 infection and progression to AIDS: Immune response genes. Tissue Antigens 2009; 74: 373-385
51. Fabio G, Scorza R, Lazzarin A, Marchini M, Zarantonello M, D'Arminio A et al. HLA-Associated susceptibility to HIV-1 infection. Clin Exp Immunol 1992; 87: 20-23
52. Vijaya LV, Rakh SS, Anu RB, Hari SPV, Pantula V, Jasti S et al. Role of HLA-B51 and HLA-B52 in susceptibility to pulmonary tuberculosis. Infect Genet Evol 2006; 6: 436-439. (Pubitemid 44566028
53. Descours B, Avettand-Fenoel V, Blanc C, Samri A, Mé lard A, Supervie V et al. Immune responses driven by protective human leukocyte antigen alleles from long-Term nonprogressors are associated with low HIV reservoir in central memory CD4 T cells. Clin Infect Dis 2012; 54: 1495-1503
54. Paximadis M, Mathebula TY, Gentle NL, Vardas E, Colvin M, Gray CM et al. Human leukocyte antigen class I (A, B, C) and II (DRB1) diversity in the black and Caucasian South African population. Hum Immunol 2012; 73: 80-92
55. Gonzalez-Galarza FF, Christmas S, Middleton D, Jones AR. Allele frequency net: A database and online repository for immune gene frequencies in worldwide populations. Nucleic Acids Res 2011; 39: D913-D919
56. Brazilian Ministry of Health: Criteria for definition of AIDS cases in adults and children [Portuguese]. DST and AIDS National Program Brasi'lia, Brazil, 2004
57. Lancaster A, Nelson MP, Meyer D, Thomson G, Single RM. PyPop: A software framework for population genomics: Analyzing large-scale multi-locus genotype data. Pac Symp Biocomput 2003: 514-525. Available at: Http://psb.stanford.edu/ psb-online/proceedings/psb03/lancaster.pdf
58. Guo SW, Thompson EA. Performing the exact test of Hardy-Weinberg proportion for multiple alleles. Biometrics 1992; 48: 361-372
59. Dean AG, Dean JA, Coulombier D, Brendel KA, Smith DC, Burton AH et al. Epi Info Version 6: A Word Processing, Database, and Statistics Program for Epidemiology on Microcomputers. 6 edn. Centers for Disease Control and Prevention: Atlanta, GA, USA, 1995
60. Carvalho MS, Andreozzi VL, Codeço CT, Campos DP, Barbosa MTS, Shimakura SE. Ana'lise de Sobrevivência: Teoria e Aplicaçöes em Sau'de. 2a edn, vol. 1. Editora FIOCRUZ: Rio de Janeiro, Brasil, 2011.